These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 11680780)

  • 1. Modulation of hormones in the treatment of lupus.
    Walker SE
    Am J Manag Care; 2001 Oct; 7(16 Suppl):S486-9. PubMed ID: 11680780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine in rheumatic and autoimmune diseases.
    McMurray RW
    Semin Arthritis Rheum; 2001 Aug; 31(1):21-32. PubMed ID: 11503136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin as a modulator of B cell function: implications for SLE.
    Peeva E; Venkatesh J; Michael D; Diamond B
    Biomed Pharmacother; 2004 Jun; 58(5):310-9. PubMed ID: 15194167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin and systemic lupus erythematosus.
    McMurray RW
    Ann Med Interne (Paris); 1996; 147(4):253-8. PubMed ID: 8952744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin has a pathogenic role in systemic lupus erythematosus.
    Jara LJ; Medina G; Saavedra MA; Vera-Lastra O; Torres-Aguilar H; Navarro C; Vazquez Del Mercado M; Espinoza LR
    Immunol Res; 2017 Apr; 65(2):512-523. PubMed ID: 28130617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocriptine treatment of systemic lupus erythematosus.
    Walker SE
    Lupus; 2001; 10(10):762-8. PubMed ID: 11721704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of systemic lupus erythematosus with bromocriptine.
    Walker SE
    Lupus; 2001; 10(3):197-202. PubMed ID: 11315352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First reported pediatric case of systemic lupus erythematosus associated with prolactinoma.
    Reuman PD
    Arthritis Rheum; 2004 Nov; 50(11):3616-8. PubMed ID: 15529390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin and gonadal hormones: a key relationship that may have clinical, monitoring and therapeutic implications in systemic lupus erythematosus.
    Lavalle C; Graef A; Baca V; Ramirez-Lacayo M; Blanco-Favela F; Ortiz O
    Lupus; 1993 Apr; 2(2):71-5. PubMed ID: 8330038
    [No Abstract]   [Full Text] [Related]  

  • 10. Bromocriptine during pregnancy in systemic lupus erythematosus: a pilot clinical trial.
    Jara LJ; Cruz-Cruz P; Saavedra MA; Medina G; García-Flores A; Angeles U; Miranda-Limón JM
    Ann N Y Acad Sci; 2007 Sep; 1110():297-304. PubMed ID: 17911444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of bromocriptine on preventing postpartum flare in systemic lupus erythematosus patients from South China.
    Qian Q; Liuqin L; Hao L; Shiwen Y; Zhongping Z; Dongying C; Fan L; Hanshi X; Xiuyan Y; Yujin Y
    J Immunol Res; 2015; 2015():316965. PubMed ID: 25973434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prolactin in stimulating disease activity in systemic lupus erythematosus.
    Walker SE; McMurray RW; Houri JM; Allen SH; Keisler D; Sharp GC; Schlechte JA
    Ann N Y Acad Sci; 1998 May; 840():762-72. PubMed ID: 9629303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of prolactin and gonadotropin-releasing hormone in rheumatic diseases.
    Walker SE; Jacobson JD
    Rheum Dis Clin North Am; 2000 Nov; 26(4):713-36. PubMed ID: 11084941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin: an immune-stimulating peptide that regulates other immune-modulating hormones.
    Walker SE
    Lupus; 1993 Apr; 2(2):67-9. PubMed ID: 8330037
    [No Abstract]   [Full Text] [Related]  

  • 15. Pituitary function in patients with newly diagnosed untreated systemic lupus erythematosus.
    Köller MD; Templ E; Riedl M; Clodi M; Wagner O; Smolen JS; Luger A
    Ann Rheum Dis; 2004 Dec; 63(12):1677-80. PubMed ID: 15082470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mood states and disease activity in patients with systemic lupus erythematosus treated with bromocriptine.
    Walker SE; Smarr KL; Parker JC; Weidensaul DN; Nelson W; McMurray RW
    Lupus; 2000; 9(7):527-33. PubMed ID: 11035419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin, dendritic cells, and systemic lupus erythematosus.
    Jara LJ; Benitez G; Medina G
    Autoimmun Rev; 2008 Jan; 7(3):251-5. PubMed ID: 18190887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays.
    Cárdenas-Mondragón G; Ulloa-Aguirre A; Isordia-Salas I; Goffin V; Leaños-Miranda A
    J Rheumatol; 2007 Jul; 34(7):1514-21. PubMed ID: 17516622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment.
    Vera-Lastra O; Mendez C; Jara LJ; Cisneros M; Medina G; Ariza R; Espinoza LR
    J Rheumatol; 2003 Oct; 30(10):2140-6. PubMed ID: 14528507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sex hormones in female patients with systemic lupus erythematosus].
    Jiang JF; Liu YH; Zhang CX
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):315-7. PubMed ID: 16045022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.